Diligence memo · auto-generated · as of July 2, 2026
VeraDermics, Inc
VeraDermics, Inc has raised $239M over 5 rounds; too few niche peers to rank its valuation yet.
Businessfiled
VeraDermics, Inc operates in Other Health Care, based in New Haven.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
VeraDermics, Inc has raised $239M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $135M on 2025-10-14.
Most recent recorded round closed around 2025-10-14.
Valuation (modeled)modeled
Provath models VeraDermics, Inc at approximately $1.0B (range $719M–$1.3B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 9 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 2.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 97% of those peers.
Closest niche peers: Wugen, Inc., HeartFlow Holding, Inc., Enable Injections, Inc.
Peoplefiled
15 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.